Chronic Wound Colonization, Infection, and Biofilms

  • Klaus Kirketerp-Møller
  • Karen Zulkowski
  • Garth James


The recognition of bacterial biofilm in chronic wounds is from 2008. The “Best Practice” treatment of chronic wounds seems to have developed a way of coping with biofilm without recognizing its presence with means like debridement and excessive fluid removal. The recognition of bacterial biofilm in chronic wounds may give us the opportunity to explain many of the characteristics of the chronic wound. It may explain why chronic wounds do not heal despite adequate treatment of underlying condition and give hope for future effective ways of treatment.


Extracellular Polymeric Substance Pressure Ulcer Chronic Wound Negative Pressure Wound Therapy Venous Ulcer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Chronic wound research in Dr. James’ laboratory is supported by grant number 5 P20 GM078445 from the National Institute of General Medical Sciences (NIGMS). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS.


  1. Akiyama H, Huh WK, Fujii K, Yamasaki O, Oono T, Iwatsuki K (2002) Confocal laser microscopic observation of glycocalyx production by Staphylococcus aureus in vitro. J Dermatol Sci 29(1):54–61CrossRefPubMedGoogle Scholar
  2. Akiyama H, Kanzaki H, Tada J, Arata J (1996) Staphylococcus aureus infection on cut wounds in the mouse skin: experimental staphylococcal botryomycosis. J Dermatol Sci 11(3):234–238CrossRefPubMedGoogle Scholar
  3. Akiyama H, Morizane S, Yamasaki O, Oono T, Iwatsuki K (2003) Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J Dermatol Sci 32(3):193–199CrossRefPubMedGoogle Scholar
  4. Alvarez OM, Mertz PM, Eaglstein WH (1983) The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds. J Surg Res 35(2):142–148CrossRefPubMedGoogle Scholar
  5. Andersen AS, Joergensen B, Bjarnsholt T et al (2010) Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots. Microbiology 156:400–407Google Scholar
  6. Ayello EA, Dowsett C, Schultz GS, Sibbald RG, Falanga V, Harding K, Romanelli M, Stacey M, TEot L, Vanscheidt W (2004) TIME heals all wounds. Nursing 34(4):36–41PubMedGoogle Scholar
  7. Bexfield A, Bond AE, Roberts EC, Dudley E, Nigam Y, Thomas S, Newton RP, Ratcliffe NA (2008) The antibacterial activity against MRSA strains and other bacteria of a <500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect 10(4):325–333CrossRefPubMedGoogle Scholar
  8. Bill TJ, Ratliff CR, Donovan AM, Knox LK, Morgan RF, Rodeheaver GT (2001) Quantitative swab culture versus tissue biopsy: a comparison in chronic wounds. Ostomy Wound Manage 47(1):34–37PubMedGoogle Scholar
  9. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16(1):2–10CrossRefPubMedGoogle Scholar
  10. Bjarnsholt T, Kirketerp-Moller K, Kristiansen S, Phipps R, Nielsen AK, Jensen PO, Hoiby N, Givskov M (2007) Silver against Pseudomonas aeruginosa biofilms. APMIS 115(8):921–928CrossRefPubMedGoogle Scholar
  11. Bowler PG, Duerden BI, Armstrong DG (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14(2):244–269CrossRefPubMedGoogle Scholar
  12. Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2(2):114–122CrossRefPubMedGoogle Scholar
  13. Davies CE, Hill KE, Wilson MJ et al (2004) Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 42:3549–3557Google Scholar
  14. Davies CE, Wilson MJ, Hill KE et al (2001) Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 9:332–340Google Scholar
  15. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD (2008) Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8, 43CrossRefPubMedGoogle Scholar
  16. Eaglstein WH Mertz PM (1978) New methods for assessing epidermal wound healing: the effects of triamcinolone acetonide and polyethelene film occlusion. J Invest Dermatol 71(6):382–384CrossRefPubMedGoogle Scholar
  17. Edwards R, Harding KG (2004) Bacteria and wound healing. Curr Opin Infect Dis 17(2):91–96CrossRefPubMedGoogle Scholar
  18. Falanga V (2000) Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen 8(5):347–352CrossRefPubMedGoogle Scholar
  19. Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA (2008) Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage Suppl:2–13Google Scholar
  20. Fazli M, Bjarnsholt T, Kirketerp-Moller K et al (2009) Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 47:4084–4089Google Scholar
  21. Frank DN, Wysocki A, Specht-Glick DD, Rooney A, Feldman RA, St Amand AL, Pace NR, Trent JD (2009) Microbial diversity in chronic open wounds. Wound Repair Regen 17(2):163–172CrossRefPubMedGoogle Scholar
  22. Gardner SE, Frantz RA, Troia C, Eastman S, MacDonald M, Buresh K, Healy D (2001) A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. Ostomy. Wound Manage 47(1):40–47PubMedGoogle Scholar
  23. Gottrup F (2004) A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg 187(5A):38S–43SCrossRefPubMedGoogle Scholar
  24. Hill KE, Davies CE, Wilson MJ, Stephens P, Harding KG, Thomas DW (2003) Molecular analysis of the microflora in chronic venous leg ulceration. J Med Microbiol 52:365–369Google Scholar
  25. Huberman L, Gollop N, Mumcuoglu KY, Breuer E, Bhusare SR, Shai Y, Galun R (2007) Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med Vet Entomol 21(2):127–131CrossRefPubMedGoogle Scholar
  26. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS (2008) Biofilms in chronic wounds. Wound Repair Regen 16(1):37–44CrossRefPubMedGoogle Scholar
  27. Jensen PO, Bjarnsholt T, Phipps R, Rasmussen TB, Calum H, Christoffersen L, Moser C, Williams P, Pressler T, Givskov M, Hoiby N (2007) Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 153(Pt 5):1329–1338CrossRefPubMedGoogle Scholar
  28. Kirketerp-Moller K, Jensen PO, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Hoiby N, Givskov M, Bjarnsholt T (2008) Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 46(8):2717–2722CrossRefPubMedGoogle Scholar
  29. Leid JG, Costerton JW, Shirtliff ME, Gilmore MS, Engelbert M (2002b) Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis. DNA Cell Biol 21(5–6):405–413CrossRefPubMedGoogle Scholar
  30. Leid JG, Shirtliff ME, Costerton JW, Stoodley AP (2002a) Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 70(11):6339–6345CrossRefPubMedGoogle Scholar
  31. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK (2005) The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 175(11):7512–7518PubMedGoogle Scholar
  32. Marshall DA, Mertz PM, Eaglstein WH (1990) Occlusive dressings. Does dressing type influence the growth of common bacterial pathogens? Arch Surg 125(9):1136–1139PubMedGoogle Scholar
  33. Mertz PM, Eaglstein WH (1984) The effect of a semiocclusive dressing on the microbial population in superficial wounds. Arch Surg 119(3):287–289PubMedGoogle Scholar
  34. Percival SL, Bowler P, Woods EJ (2008) Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 16(1):52–57CrossRefPubMedGoogle Scholar
  35. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, Bowers J, Rattray R, Ravel J, Kingsley C, Keim PS, Lazarus GS, Zenilman JM (2009) Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 4(7):e6462CrossRefPubMedGoogle Scholar
  36. Rhoads DD, Wolcott RD, Percival SL (2008) Biofilms in wounds: management strategies. J Wound Care 17(11):502–508PubMedGoogle Scholar
  37. Robson MC, Stenberg BD, Heggers JP (1990) Wound healing alterations caused by infection. Clin Plast Surg 17(3):485–492PubMedGoogle Scholar
  38. Tarnuzzer RW, Schultz GS (1996) Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 4(3):321–325CrossRefPubMedGoogle Scholar
  39. Trengove NJ, Langton SR, Stacey MC (1996a) Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 4(2):234–239CrossRefPubMedGoogle Scholar
  40. Trengove NJ, Stacey MC, McGechie DF, Mata S (1996b) Qualitative bacteriology and leg ulcer healing. J Wound Care 5(6):277–280PubMedGoogle Scholar
  41. van der Plas MJ, Jukema GN, Wai SW, Dogterom-Ballering HC, Lagendijk EL, van, Gulpen C, van Dissel JT, Bloemberg GV, Nibbering PH (2008) Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 61(1):117–122CrossRefPubMedGoogle Scholar
  42. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, Deleo FR, Otto M (2004) Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6(3):269–275CrossRefPubMedGoogle Scholar
  43. Werthen M, Davoudi M, Sonesson A, Nitsche DP, Morgelin M, Blom K, Schmidtchen A (2004) Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J Antimicrob Chemother 54(4):772–779CrossRefPubMedGoogle Scholar
  44. Wolcott RD, Rhoads DD (2008a) A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 17(4):145–2, 154PubMedGoogle Scholar
  45. Wolcott RD, Rhoads DD (2008b) A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 17(4):145–2, 154PubMedGoogle Scholar
  46. Wolcott RD, Kennedy JP, Dowd SE (2009) Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 18(2):54–56PubMedGoogle Scholar
  47. Yager DR, Nwomeh BC (1999) The proteolytic environment of chronic wounds. Wound Repair Regen 7(6):433–441CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Klaus Kirketerp-Møller
    • 1
  • Karen Zulkowski
    • 2
  • Garth James
    • 3
  1. 1.Koege University HospitalKoegeDenmark
  2. 2.College of NursingMontana State UniversityBozemanUSA
  3. 3.Center for Biofilm EngineeringMontana State UniversityBozemanUSA

Personalised recommendations